Chongqing University Cancer Hospital (Chongqing Cancer Hospital)
重庆大学附属肿瘤医院（重庆市肿瘤医院）
Chongqing
Hospital photos
1 / 3
Overview
Founded in 1943, Chongqing University Cancer Hospital is a national tertiary Grade A oncology specialty hospital incorporating Chongqing Cancer Hospital, Chongqing Cancer Institute, and Chongqing Cancer Center functions.
Why this hospital
Full-chain cancer care spanning prevention, screening, diagnosis, treatment, and rehabilitation.
Clinical capabilities
Complex case management
A comprehensive oncology specialty hospital covering prevention, screening, diagnosis, surgery, radiotherapy, systemic treatment, clinical research, rehabilitation, and palliative care, supported by advanced precision-surgery, radiotherapy, and molecular-imaging platforms.
Key departments
Departments and specialty centers known for their expertise
Thoracic Tumor Center (Lung Cancer/Mediastinal Tumors)
Specialty center
Integrates thoracic surgery, respiratory oncology, radiotherapy, and interventional therapy using the MDT model; performs early screening, EGFR/ALK and other molecular subtyping, immunotherapy, and SBRT; complex stage IIIB and a few oligometastatic lesions are treated with sequential or synchronous chemoradiotherapy and immunotherapy.
Gastrointestinal Tumor Center (Esophagus/Stomach/Colorectal)
Specialty center
Standardized ERAS pathways and laparoscopic/da Vinci minimally invasive resection, combined with perioperative neoadjuvant therapy; performs MSI-H/dMMR precision medication, circulating tumor DNA monitoring of recurrence risk, and guidance of adjuvant therapy.
Hepatobiliary and Pancreatic Tumor Center
Specialty center
Jointly provides TACE/TARE, ablation, portal vein embolization PVE, and two-step hepatectomy and other conversion therapies with hepatobiliary surgery, interventional department, and hepatology department; precision sequencing guides TKI + immunotherapy combination regimens.
Breast Tumor Center
Specialty center
Provides full-course management (screening-preoperative neoadjuvant-postoperative adjuvant-follow-up), integrating breast-conserving surgery and breast reconstruction; performs antibody-drug conjugate (ADC) therapy and multidisciplinary radiotherapy enhancement for HER2 low-expressing populations.
Gynecologic Oncology Center
Specialty center
Comprehensive diagnosis and treatment of cervical cancer, ovarian cancer, and endometrial cancer; performs laparoscopic/robotic precision staging and tumor cytoreduction surgery; standardized screening and treatment of HPV-related precancerous lesions and integrated radiotherapy and chemotherapy.
Urological Oncology Center
Specialty center
Standardized diagnosis and treatment of prostate cancer, kidney cancer, and bladder cancer; da Vinci robots are widely used in nerve-sparing radical surgery; PSMA PET imaging provides precise staging, and minimally invasive bladder replacement and bladder preservation strategies are implemented in parallel.
Head and Neck Tumor Center
Specialty center
Individualized radiotherapy and chemotherapy for nasopharyngeal carcinoma, laryngeal cancer, and oral cancer; IMRT/VMAT high-precision radiotherapy protects salivary glands and key organs at risk, and reconstructive surgery improves function and appearance.
Hematologic Oncology and Hematopoietic Stem Cell Transplantation Center
Specialty center
Comprehensive treatment of leukemia, lymphoma, and multiple myeloma; provides autologous/allogeneic transplantation and CAR-T clinical research platform support, and strictly controls infection and complication management.
Neuro-Oncology Center (Glioma/Metastatic Tumors)
Specialty center
Perioperative neuronavigation and intraoperative functional monitoring; radiotherapy uses SRS/SRT combined with temozolomide, tumor-treating fields (TTFields) and other multimodal regimens.
Interventional Oncology and Minimally Invasive Ablation Center
Specialty center
Provides TACE/TARE, portal vein/vena cava stents, radiofrequency/microwave/cryoablation and other minimally invasive comprehensive technologies, and image fusion navigation improves targeting accuracy.
Nuclear Medicine and Molecular Imaging Center
Specialty center
Performs FDG and specific tracer PET-CT staging and efficacy evaluation; standardized 131I treatment for thyroid cancer and targeted radioactive ligand therapy such as PRRT/PSMA (carried out according to qualifications).
Precision Medicine and Pathological Molecular Diagnosis Center
Specialty center
Covers NGS 500+ gene panels, fusion/copy number detection, and TMB/MSI assessment; provides medication companion diagnostics, micro-metastasis/minimal residual disease (MRD) monitoring.
Advanced equipment
Hybrid operating room
Dual-source CT
PET/MR
PET/CT
EDGE stereotactic radiotherapy system
TOMO helical radiotherapy system
BSD2000 deep-tumor phased-array hyperthermia system
INTRABEAM intraoperative radiotherapy system
Frequently asked questions
Common questions from international patients
Compiled from the hospital's official website and other public sources. Details may change, so please confirm with us before you travel.
Chongqing Hygeia Hospital is affiliated with Hygeia Medical Group, a Hong Kong main board listed company with investment from central enterprises, and is among China's top 500 listed companies. The group integrates the research and development, production and manufacturing of large-scale medical equipment, and the operation and management of chain hospitals. Hygeia owns more than 20 wholly-owned hospitals nationwide. As of now, there are nearly 20,000 open beds and approximately 15,000 employees. The business spans over ten provinces including Shanghai, Chongqing, Jiangsu, Shandong, Shaanxi, Fujian, Guangxi, and Yunnan. Chongqing Hygeia Hospital covers an area of 83 acres, with a planned construction area of approximately 180,000 square meters and a total investment of about 2 billion yuan. It is established with the approval of the Chongqing Municipal Health Commission and built according to the standards of a tertiary first-class hospital, featuring oncology prevention and treatment as its specialty. It is a key livelihood project in Chongqing High-tech Zone and serves as a teaching hospital for the School of Life Sciences and the School of Bioengineering at Chongqing University. The hospital integrates clinical, scientific research, prevention, and teaching, with a planned capacity of 1,800 beds.
Founded in 1956, the hospital is a tertiary Grade A comprehensive children's hospital and national pediatric regional medical center operating Yuzhong and Liangjiang campuses in Chongqing, with affiliated regional hospitals in Jiangxi and Yibin.
Founded in 1939 and also known as Chongqing Fourth People's Hospital and Chongqing University Central Hospital, the center is a tertiary Grade A teaching hospital integrating municipal emergency dispatch, medical care, research, teaching, prevention, and public rescue.
